Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Primary Efficacy Analyses of NeoRHEA, Neoadjuvant Biomarker Research Study of Palbociclib Combined With ET in ER+/HER2- BC"

217 views
June 9, 2023
Comments 0
Login to view comments. Click here to Login